Good News From Oxford & Astra Zeneca In Vaccine Study

Promising data has been coming from Oxford University & Astra Zeneca as they continue the search for a coronavirus vaccine.

The newest round of the vaccine has generated an immune response in 1000 patients participating in a study. While side effects like headache, fever, muscle pains and injection site reactions are present in about 60% of patients, they all reported them as being mild.

The new data is showing that this might be a safe vaccine that can be mass produced and distributed by the billions.

During a press conference, Pascal Soriot, AstraZeneca’s CEO said:

“At the end of the day, you have to prioritize efficacy and then resolve the challenges around the logistics of the trial or logistics of manufacturing large quantities of vaccine.”

Source:
Statnews.com